Showing results (181-190 of 215) with videos related to

Sort By:
Pageof 22
Trials|August 19, 2020
An open-label, randomized, non-inferiority trial of the efficacy and safety of ciprofloxacin versus streptomycin + ciprofloxacin in the treatment of bubonic plague (IMASOY): study protocol for a randomized control trialRindra Vatosoa Randremanana, Mihaja Raberahona, Mamy Jean de Dieu Randria, et al.
Plos Neglected Tropical Diseases|February 2, 2018
Improved tools and strategies for the prevention and control of arboviral diseases: A research-to-policy forumPiero Olliaro, Florence Fouque, Axel Kroeger, et al.
Antimicrobial Agents and Chemotherapy|October 27, 2004
In vivo assessment of drug efficacy against Plasmodium falciparum malaria: duration of follow-upKasia Stepniewska, Walter R J Taylor, Mayfong Mayxay, et al.
Infection|January 23, 2019
The diagnosis and treatment of urogenital schistosomiasis in Italy in a retrospective cohort of immigrants from Sub-Saharan AfricaMarta Tilli, Federico Gobbi, Francesca Rinaldi, et al.
Emerging Infectious Diseases|February 21, 2025
Adaptive Design for Phase II/III Platform Trial of Lassa Fever TherapeuticsJosephine Bourner, Michel Vaillant, Alex Paddy Abdel Salam, et al.
The Lancet. Respiratory Medicine|June 17, 2022
A core outcome set for post-COVID-19 condition in adults for use in clinical practice and research: an international Delphi consensus studyDaniel Munblit, Timothy Nicholson, Athena Akrami, et al.
Plos Neglected Tropical Diseases|October 21, 2014
Evaluation of commercially available diagnostic tests for the detection of dengue virus NS1 antigen and anti-dengue virus IgM antibodyElizabeth A Hunsperger, Sutee Yoksan, Philippe Buchy, et al.
Plos Neglected Tropical Diseases|March 16, 2026
A prospective cohort study to describe the morphology of buboes in patients with bubonic plague using ultrasound imagingJosephine Bourner, Reena Dwivedi, Rindra Vatosoa Randremanana, et al.
Lancet (London, England)|January 25, 2011
Comparison of short-course multidrug treatment with standard therapy for visceral leishmaniasis in India: an open-label, non-inferiority, randomised controlled trialShyam Sundar, Prabhat Kumar Sinha, Madhukar Rai, et al.
The New England Journal of Medicine|August 6, 2025
Ciprofloxacin versus Aminoglycoside-Ciprofloxacin for Bubonic PlagueRindra Vatosoa Randremanana, Mihaja Raberahona, Josephine Bourner, et al.
Pageof 22